Apatinib

Apatinib Reactions 1680, p51 - 2 Dec 2017 Multiple skin rash and oral ulcers: case report An adult man [age at the time of reaction onset not stated] developed multiple skin rash and oral ulcers during treatment with apatinib [route not stated]. The man, who was diagnosed with renal epithelioid angiomyolipoma with liver and abdomen metastasis, started receiving treatment with apatinib 500 mg/day on 10 January 2016. After two week of apatinib therapy, he developed apparent level III side effects, which included multiple skin rash and oral ulcers. His apatinib dose was reduced to half [outcomes not stated]. Author comment: "After 2 weeks of [apatinib], his appetite and abdominal distension improved, but he demonstrated apparent level III side effects, including multiple skin rash and oral ulcers, thus, the dosage was reduced by half." Ge X, et al. Successful treatment of liver and abdomen metastasis of renal epithelioid angiomyolipoma with apatinib: A case report. Translational Cancer Research 6: 1015-1019, No. 5, Oct 2017. Available from: URL: http:// doi.org/10.21037/tcr.2017.08.41 - China 803284665 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Apatinib

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/apatinib-Z3b7ZDJbyO
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-38982-1
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p51 - 2 Dec 2017 Multiple skin rash and oral ulcers: case report An adult man [age at the time of reaction onset not stated] developed multiple skin rash and oral ulcers during treatment with apatinib [route not stated]. The man, who was diagnosed with renal epithelioid angiomyolipoma with liver and abdomen metastasis, started receiving treatment with apatinib 500 mg/day on 10 January 2016. After two week of apatinib therapy, he developed apparent level III side effects, which included multiple skin rash and oral ulcers. His apatinib dose was reduced to half [outcomes not stated]. Author comment: "After 2 weeks of [apatinib], his appetite and abdominal distension improved, but he demonstrated apparent level III side effects, including multiple skin rash and oral ulcers, thus, the dosage was reduced by half." Ge X, et al. Successful treatment of liver and abdomen metastasis of renal epithelioid angiomyolipoma with apatinib: A case report. Translational Cancer Research 6: 1015-1019, No. 5, Oct 2017. Available from: URL: http:// doi.org/10.21037/tcr.2017.08.41 - China 803284665 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off